CIK: 0001017645 · Show all filings
Period: Q4 2024 (← Previous) (Next →)
Filing Date: Feb 7, 2025
Total Value ($000): $2,809,302 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| DLO | DLOCAL | 63,906,695 | $719,589 | 25.6% | $34.47 | -72.2% | CL A | G29018101 |
| ALHC | ALIGNMENT HEALTHCARE | 60,993,323 | $686,175 | 24.4% | $19.55 | -40.2% | COM | 01625V104 |
| ALKT | ALKAMI | 9,645,318 | $353,790 | 12.6% | $36.66 | +1.8% | COM | 01644J108 |
| XP | XP, INC | 29,617,733 | $350,970 | 12.5% | $31.26 | -49.7% | CL A | G98239109 |
| CNTA | CENTESSA PHARMACEUTICALS | 9,681,818 | $162,170 | 5.8% | $17.55 | — | ADS | 152309100 |
| — | AKERO THERAPEUTICS | 5,233,989 | $145,610 | 5.2% | $32.57 | — | COM | 00973Y108 |
| PHVS | PHARVARIS | 7,531,252 | $144,374 | 5.1% | $22.20 | -7.3% | COM | N69605108 |
| EWCZ | EUROPEAN WAX CENTER | 13,110,492 | $87,447 | 3.1% | $22.36 | -70.6% | CL A | 29882P106 |
| RPRX | ROYALTY PHARMA | 1,500,000 | $38,265 | 1.4% | $49.50 | -46.4% | CL A | G7709Q104 |
| IMCR | IMMUNOCORE | 1,261,684 | $37,220 | 1.3% | $50.86 | — | ADS | 45258D105 |
| — | THIRD HARMONIC BIO | 3,372,323 | $34,701 | 1.2% | $17.91 | — | COM | 88427A107 |
| RSKD | RISKIFIED | 5,324,998 | $25,187 | 0.9% | $28.06 | -83.5% | CL A | M8216R109 |
| — | ACELYRIN | 2,695,327 | $8,463 | 0.3% | $15.74 | — | COM | 00445A100 |
| ADAG | ADAGENE | 3,825,952 | $7,614 | 0.3% | $3.09 | — | ADS | 005329107 |
| — | WISH | 609,616 | $4,286 | 0.2% | $6.58 | — | CL A | 21077C305 |
| GROV | GROVE COLLABORATIVE | 2,474,859 | $3,440 | 0.1% | $1.69 | -18.4% | CL A | 39957D201 |